Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank50
3Y CAGR-13.3%
5Y CAGR+39.9%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-13.3%/yr
vs +341.4%/yr prior
5Y CAGR
+39.9%/yr
Recent deceleration
Acceleration
-354.6pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
5.4x
Strong expansion
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.04 | +19.5% |
| 2024 | 0.03 | +186.1% |
| 2023 | -0.04 | -163.4% |
| 2022 | 0.06 | +593.5% |
| 2021 | 0.01 | +18.7% |
| 2020 | 0.01 | -86.8% |
| 2019 | 0.06 | +34793.1% |
| 2018 | 0.00 | -65.8% |
| 2017 | 0.00 | -93.0% |
| 2016 | 0.01 | - |